Human leukocyte antigen-G1 inhibits natural killer cytotoxicity through blocking the activating signal transduction pathway and formation of activating immunologic synapse

Human Immunology

Volumn 69, Issue 1, 2008, Pages 16-23

  Yu, Yanrong ^a,b   Wang, Yun ^a   Feng, Meifu ^a  

^a INSTITUTE OF ZOOLOGY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Cytotoxicity; HLA G1; Immunosynapse; Natural killer cells; Signal transduction

Indexed keywords

ACTIN; HLA G ANTIGEN; HLA G1 ANTIGEN; PERFORIN; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; NATURAL KILLER CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYNAPTIC POTENTIAL;

CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; K562 CELLS; KILLER CELLS, NATURAL; MAP KINASE SIGNALING SYSTEM; MICROFILAMENTS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; PROTO-ONCOGENE PROTEINS C-VAV;

EID: 39549089699     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2007.11.005     Document Type: Article

References (31)

1. Kovats S., Main E., Librach C., Stubblebine M., Fisher S.J., and DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 248 (1990) 220
2. Rouas-Freiss N., Goncalves R.M., Manier C., Dausset J., and Carosella E.D. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 94 (1997) 11520
3. Bainbridge D., Ellis S., Le Bouteiller P., and Sargent L. HLA-G remains a mystery. Trends in immunology 22 (2001) 548
4. Ishitani A., and Geraghty D.E. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II molecules. Proc Natl Acad Sci USA 89 (1992) 3947
5. Kirszenbaum M., Moreau P., and Gluckman E. An alternatively spliced form of HLA-G mRNA in human trophoblast and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc Natl Acad Sci USA 91 (1994) 4209
6. Paul P., Cabestre F.A., Ibrahim E.C., Lefebvre S., Khalil-Daher I., Vazeux G., et al. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol 61 (2000) 1138
7. Tripathi P., Abbas A., Naik S., and Agrawal S. Role of 14-bp deletion in the HLA-G gene in the maintenance of pregnancy. Tissue Antigens 64 (2004) 706
8. Paul P., Rouas-Freiss N., Khalil-Daher I., Moreau P., Riteau B., Le Gal F.A., et al. HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA 95 (1998) 4510
9. Bukur J., Rebmann V., Grosse-Wilde H., Luboldt H., Ruebben H., Drexler I., et al. Functional role of human leukocyte antigen-G upregulation in renal cell carcinoma. Cancer Res 63 (2003) 4107
10. Wiendl H., Mitsdoerffer M., Hofmeister V., Wischhusen J., Bornemann A., Meyermann R., et al. A functional role of HLA-G expression in human gliomas: An alternative strategy of immune escape. J Immunol 168 (2002) 4772
11. Rouas-Freiss N., Moreau P., Menier C., and Carosella E.D. HLA-G in cancer: A way to turn off the immune system. Semin Cancer Biol 13 (2003) 325
12. Shiroishi M., Tsumoto K., Amano K., Shirakihara Y., Colonna M., Braud V.M., et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci USA 100 (2003) 8856
13. Rajagopalan S., and Long E.O. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 189 (1999) 1093
14. Hofmeister V., and Weiss E.H. HLA-G modulates immune responses by diverse receptor interactions. Semin Cancer Biol 13 (2003) 317
15. Lanier L.L. Natural killer cell receptor signaling. Curr Opin Immunol 15 (2003) 308
16. Zompi S., and Colucci F. Anatomy of a murder-signal transduction pathways leading to activation of natural killer cells. Immunol Lett 97 (2005) 31
17. Vivier E., Nunes J.A., and Vely F. Natural killer cell signaling pathways. Science 306 (2004) 1517
18. Yao A.Y., Tang H.Y., Wang Y., Feng M.F., and Zhou R.L. Inhibition of the activating signals in NK92 cells by recombinant GST-sHLA-G1α chain. Cell Res 14 (2004) 155
19. Zhou J.J., Qu H., Wu C.H., Han W.D., Li Z.W., and Feng M.F. Molecular cloning, sequence analysis and protein structure modeling of immunotolerance related HLA-G1 from Chinese. Acta Scientiarum Naturalium Universitatis Rekinensis [in Chinese] 38 (2002) 212
20. Khalil-Daher I., Riteau B., Menier C., Sedlik C., Paul P., Dausset J., et al. Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself. J Reprod Immunol 43 (1999) 175
21. Burshtyn D.B., Shin J., Stebbins C., and Long E.O. Adhesion to target cells is disrupted by the killer cell inhibitory receptor. Curr Biol 10 (2000) 777
22. Wei S., Gamero A.M., Liu J.H., Daulton A.A., Valkov N.I., Trapani J.A., et al. Control of lytic function by mitogen-activated protein kinase/extracellular regulatory kinase 2 (ERK2) in a human natural killer cell line: Identification of perforin and granzyme B mobilization by functional ERK2. J Exp Med 187 (1998) 1753
23. Djeu J.Y., Jiang K., and Wei S. A view to a kill: Signals triggering cytotoxicity. Clin Cancer Res 8 (2002) 636
24. Jiang K., Zhong B., Gilvary D.L., Corliss B.C., Vivier E., Hong-Geller E., et al. Syk regulation of phosphoinositide 3-kinase-dependent NK cell function. J Immunol 168 (2002) 3155
25. Stebbins C.C., Watzl C., Billadeau D.D., Leibson P.J., Burshtyn D.N., and Long E.O. Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol Cell Biol 23 (2003) 6291
26. Cella M., Fujikawa K., Tassi I., Kim S., Latinis K., Nishi S., et al. Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity. J Exp Med 200 (2004) 817
27. Barber D.F., Faure M., and Long E.O. LFA-1 contributes an early signal for NK cell cytotoxicity. J Immunol 173 (2004) 3653
28. Riteau B., Barber D.F., and Long E.O. Vav1 phosphorylation is induced by b2 integrin engagement on natural killer cells upstream of actin cytoskeleton and lipid raft reorganization. J Exp Med 198 (2003) 469
29. Hornstein I., Alcover A., and Katzav S. Vav proteins, masters of the world of cytoskeleton organization. Cell Signal 16 (2004) 1
30. Jiang K., Zhong B., Gilvary D.L., Corliss B.C., Hong-Geller E., Wei S., et al. Pivotal role of phosphoinositide-3 kinase in regulate of cytotoxicity in natural killer cells. Nature Immunol 1 (2000) 419
31. Orange J.S., Harris K.E., Andzelm M.M., Valter M.M., Geha R.S., and Strominger J.L. The mature activating natural killer cell immunologic synapse is formed in distinct stages. Proc Natl Acad Sci USA 100 (2003) 14151